← Open Payments lookup

REBECCA HARRIS: Open Payments

NPI 1629014352 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$633 in 34 payments from 10 companies in 2025. Trend: 2023 $429 · 2024 $301 · 2025 $633

Food & beverage: $633
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.17$324
Astellas Pharma US Inc7$122
Bayer Healthcare Pharmaceuticals Inc.3$53
Exeltis, USA Inc.1$24
Supernus Pharmaceuticals, Inc.1$20
Sage Therapeutics, LLC1$20
ABBVIE INC.1$19
SHIELD THERAPEUTICS INC1$19
MAYNE PHARMA COMMERCIAL LLC1$16
Amgen Inc.1$14

Products named: MYFEMBREE, GEMTESA, Veozah, Mirena, SLYND, Qelbree, ZURZUVAE, UBRELVY.

Industry payments across AL — which companies pay providers there.